Page 9 - Cipla

Cipla, Torrent may need to divest 15 brands in buyout deal: Bernstein

Torrent has a strong presence in gastrointestinal, neurology, and cardiac segments

Cipla plans acquisitions to take top spot in South African drug market

Cipla has a strong presence in both private and tender markets in South Africa

Stocks to Watch: Vishnu Prakash, Hero Moto, Cipla, Escorts, Oil, IEX, M&M

Stocks to watch on September 5, 2023: Vishnu Prakash R Punglia will debut on the bourses today. The issue price is Rs 99 and the stock may list with up to 60 per cent premium

Torrent leads race to acquire Cipla with 30% higher offer than Blackstone's

Shares of Cipla closed at Rs 1,239 apiece on the BSE on Monday, with a market valuation of Rs 1 trillion

Torrent Pharma gears up to buyout Cipla promoters, approach PE funding

Torrent Pharma might pay a total of Rs 60,000 crore (around $7.2 billion) for a 59.47 per cent stake in the 88-year-old pharmaceutical company

Stocks to Watch: Torrent Pharma, Cipla, TVS Supply Chain, Titan, AdaniTotal

Stocks to Watch on August 23, 2023: Torrent Pharma has joined the race to buy out Cipla's promoter stake held by the Hamied family, reported The Economic Times

Sensex falls 388 pts, Nifty holds 19,350 amid weak global cues; PSBs outrun

Closing Bell on August 17, 2023: On the upside, only the Nifty PSU Bank index (up 1.5 per cent) outperformed the markets

Stocks to Watch today, Aug 17: Auto, M&M, Railway, IRFC, Cipla, Nava, SAIL

Stocks to watch on August 17, 2023: Balrampur Chini, Delta Corp, GNFC, Indiabulls Housing Finance, India Cements, SAIL and Zee among 11 stocks in F&O ban on Thursday.

Cipla's impending 'takeover' by Blackstone should sadden all of us: Jairam

Senior Congress leader Jairam Ramesh on Friday said Indian pharmaceutical company Cipla is an integral part of the country's political, economic and social history and its "impending takeover" by Blackstone should sadden everyone. The Congress general secretary shared a media report on Twitter which claimed that Blackstone, the world's largest private equity fund, is set to submit a non-binding bid as early as next week to acquire the entire 33.47 per cent promoter stake in Cipla. "It was painful to learn that Blackstone, the world's largest private equity fund, is negotiating to acquire the entire 33.47% promoter stake in Cipla, India's oldest pharmaceutical company," Ramesh, who is the chairman of Parliamentary standing committee on science and technology, environment and climate change, said. Cipla was established in 1935 by Khwaja Abdul Hamied, who was profoundly impacted by Mahatma Gandhi, Jawaharlal Nehru, Sardar Patel and Maulana Abul Kalam Azad. He also played an important

Cipla hits new high; up 6% on promoter stake sale buzz, strong Q1 results

With regards to the promoters stake sale buzz, the company said it will make appropriate disclosure in compliance with the Listing Regulations as and when any such requirement arises.

Stocks to Watch: Bharti Airtel, Adani Ent, Cipla, RailTel, Indian Hotels

Stocks to Watch on July 28, 2023: Despite a 10 per cent increase in revenue, telecom provider Airtel Africa announced a net loss of $151 million in the first quarter (April-June) of FY24 on Thursday

Blackstone, Baring in race to acquire up to 20% stake in pharma firm Cipla

Cipla shares closed 9.6 per cent up on Thursday to Rs. 1,175

Never again will India be starved of essential drugs, says Cipla founder

As of July 27, Cipla's market cap stands at Rs 94572 crore

Top shareholders of drugmaker Cipla looking to sell stake: Report

The company has hired an investment bank to advise on the deal, the report said

Cipla surges 9% on strong Q1 results, raises FY24 margin guidance

For FY24, Cipla raised its EBITDA margin guidance to 23 per cent from 22 per cent earlier.

Cipla Q1FY24 result: Net profit at Rs 895.02 crore; revenue up by 12.2%

The company's One-India business grew by 12 per cent YoY. Their US business reported highest-ever revenue of $222 million and 43 per cent YoY growth

Cipla Q1 preview: India biz may push profit over 50% QoQ; US sales to drag

Cipla Q1 preview: The company's domestic business can grow 15 per cent quarter-on-quarter (QoQ), while US business could contract by up to 4 per cent QoQ to $195 million

Cipla's US unit recalls 6 batches of bronchospasm inhaler over defect

'The company is initiating a recall in the US due to a market complaint for one single inhaler, where leakage was observed through the inhaler valve,' the pharmaceutical company said in a statement

Delhi HC restrains Cipla from using Gluco-C or Gluco-D trademarks

Zydus argued that Cipla started branding its Glucose product under Gluco C ++ and Gluco D ++, in order to create confusion in the minds of customers

Stocks to watch: Coal India, Mankind Pharma, EID Parry, India Pesticides

Stocks to watch on June 1, 2023: From Coal India to Mankind Pharma, here are top stocks to watch in Thursday's trading session